Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding
Therapeutic carbohydrate restriction diets have been becoming increasingly popular over the years, resulting in dramatic weight loss and an improvement in metabolic disorders. Obesity, insulin resistance, and diabetes are the risk factors for many gynecologic morbidities such as uterine leiomyoma, e...
Gespeichert in:
| Veröffentlicht in: | Nutrients 2023-08, Vol.15 (17), p.3760 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 17 |
| container_start_page | 3760 |
| container_title | Nutrients |
| container_volume | 15 |
| creator | Salcedo, Andrea C Yun, Jane Carter, Cody Hart, Elaine |
| description | Therapeutic carbohydrate restriction diets have been becoming increasingly popular over the years, resulting in dramatic weight loss and an improvement in metabolic disorders. Obesity, insulin resistance, and diabetes are the risk factors for many gynecologic morbidities such as uterine leiomyoma, endometrial polyps, and polycystic ovarian syndrome. There is evidence suggesting that the pathogenesis of cardiovascular disease is similar to that seen in many causes of abnormal uterine bleeding. We aim to explain how cardiovascular disease risk factor reduction with the use of therapeutic carbohydrate restriction may prevent and potentially treat these gynecologic disorders. |
| doi_str_mv | 10.3390/nu15173760 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10490487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A764267947</galeid><sourcerecordid>A764267947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6b8f0787953fcd431372aa74e5ea2cab5c490fe768b7c9a5b07fb85af057c2ce3</originalsourceid><addsrcrecordid>eNptkt9rFDEQx4MottS--AdIwBcRrmaT7Gb3Sa6HrUKLItfnMJud3KXsJmc2Wzj_erNc7Q8xecgw-cx3MpMh5G3BzoRo2Cc_FWWhhKrYC3LMmeKLqpLi5RP7iJyO4y2bl2KqEq_JUcbrSjX8mPxebzHCDqfkDF1BbMN230VISH_imKIzyQVPYaRArzFBG_rMXYcOepf21IZI0xbpj4h36A-o7-g6IqQhO2iwdNn6EAfo6U3C6DzS8x6xc37zhryy0I94en-ekJuLL-vV18XV98tvq-XVwkgl06Jqa8tUrZpSWNNJUQjFAZTEEoEbaEsjG2YxV9Qq00DZMmXbugTLSmW4QXFCPh90d1M7YGfyuyL0ehfdAHGvAzj9_Ma7rd6EO12wrCxrlRU-3CvE8GvKfdGDGw32PXgM06h5XQnBZCVYRt__g96GKfpc30xxxeqSiUdqAz1q523Iic0sqpeqkjz_jZzTnv2HyrvDwZng0brsfxbw8RBgYhjHiPahyILpeVr047Rk-N3Ttjygf2dD_AHXmLrV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2862708503</pqid></control><display><type>article</type><title>Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding</title><source>Electronic Journals Library</source><source>Open Access: PubMed Central</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>PubMed Central Open Access</source><creator>Salcedo, Andrea C ; Yun, Jane ; Carter, Cody ; Hart, Elaine</creator><creatorcontrib>Salcedo, Andrea C ; Yun, Jane ; Carter, Cody ; Hart, Elaine</creatorcontrib><description>Therapeutic carbohydrate restriction diets have been becoming increasingly popular over the years, resulting in dramatic weight loss and an improvement in metabolic disorders. Obesity, insulin resistance, and diabetes are the risk factors for many gynecologic morbidities such as uterine leiomyoma, endometrial polyps, and polycystic ovarian syndrome. There is evidence suggesting that the pathogenesis of cardiovascular disease is similar to that seen in many causes of abnormal uterine bleeding. We aim to explain how cardiovascular disease risk factor reduction with the use of therapeutic carbohydrate restriction may prevent and potentially treat these gynecologic disorders.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu15173760</identifier><identifier>PMID: 37686792</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Atherosclerosis ; Carbohydrates ; Cardiovascular disease ; Cardiovascular Diseases ; Care and treatment ; Cytokines ; Diet, Carbohydrate-Restricted ; Disease prevention ; Endometrium ; Epidermal growth factor ; Female ; Fibroids ; Health aspects ; Health care policy ; Humans ; Hyperplasia ; Hypertension ; Hysterectomy ; Inflammation ; Insulin resistance ; Leiomyoma ; Medical care, Cost of ; Menstruation ; Metabolism ; Obesity ; Opinion ; Ovaries ; Polycystic ovary syndrome ; Polyps ; Prevention ; Risk factors ; Smooth muscle ; Tumor necrosis factor-TNF ; Uterine bleeding ; Uterine Hemorrhage ; Vascular endothelial growth factor ; Weight control ; Women ; Womens health</subject><ispartof>Nutrients, 2023-08, Vol.15 (17), p.3760</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6b8f0787953fcd431372aa74e5ea2cab5c490fe768b7c9a5b07fb85af057c2ce3</citedby><cites>FETCH-LOGICAL-c474t-6b8f0787953fcd431372aa74e5ea2cab5c490fe768b7c9a5b07fb85af057c2ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490487/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490487/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37686792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salcedo, Andrea C</creatorcontrib><creatorcontrib>Yun, Jane</creatorcontrib><creatorcontrib>Carter, Cody</creatorcontrib><creatorcontrib>Hart, Elaine</creatorcontrib><title>Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>Therapeutic carbohydrate restriction diets have been becoming increasingly popular over the years, resulting in dramatic weight loss and an improvement in metabolic disorders. Obesity, insulin resistance, and diabetes are the risk factors for many gynecologic morbidities such as uterine leiomyoma, endometrial polyps, and polycystic ovarian syndrome. There is evidence suggesting that the pathogenesis of cardiovascular disease is similar to that seen in many causes of abnormal uterine bleeding. We aim to explain how cardiovascular disease risk factor reduction with the use of therapeutic carbohydrate restriction may prevent and potentially treat these gynecologic disorders.</description><subject>Atherosclerosis</subject><subject>Carbohydrates</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases</subject><subject>Care and treatment</subject><subject>Cytokines</subject><subject>Diet, Carbohydrate-Restricted</subject><subject>Disease prevention</subject><subject>Endometrium</subject><subject>Epidermal growth factor</subject><subject>Female</subject><subject>Fibroids</subject><subject>Health aspects</subject><subject>Health care policy</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Hypertension</subject><subject>Hysterectomy</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Leiomyoma</subject><subject>Medical care, Cost of</subject><subject>Menstruation</subject><subject>Metabolism</subject><subject>Obesity</subject><subject>Opinion</subject><subject>Ovaries</subject><subject>Polycystic ovary syndrome</subject><subject>Polyps</subject><subject>Prevention</subject><subject>Risk factors</subject><subject>Smooth muscle</subject><subject>Tumor necrosis factor-TNF</subject><subject>Uterine bleeding</subject><subject>Uterine Hemorrhage</subject><subject>Vascular endothelial growth factor</subject><subject>Weight control</subject><subject>Women</subject><subject>Womens health</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkt9rFDEQx4MottS--AdIwBcRrmaT7Gb3Sa6HrUKLItfnMJud3KXsJmc2Wzj_erNc7Q8xecgw-cx3MpMh5G3BzoRo2Cc_FWWhhKrYC3LMmeKLqpLi5RP7iJyO4y2bl2KqEq_JUcbrSjX8mPxebzHCDqfkDF1BbMN230VISH_imKIzyQVPYaRArzFBG_rMXYcOepf21IZI0xbpj4h36A-o7-g6IqQhO2iwdNn6EAfo6U3C6DzS8x6xc37zhryy0I94en-ekJuLL-vV18XV98tvq-XVwkgl06Jqa8tUrZpSWNNJUQjFAZTEEoEbaEsjG2YxV9Qq00DZMmXbugTLSmW4QXFCPh90d1M7YGfyuyL0ehfdAHGvAzj9_Ma7rd6EO12wrCxrlRU-3CvE8GvKfdGDGw32PXgM06h5XQnBZCVYRt__g96GKfpc30xxxeqSiUdqAz1q523Iic0sqpeqkjz_jZzTnv2HyrvDwZng0brsfxbw8RBgYhjHiPahyILpeVr047Rk-N3Ttjygf2dD_AHXmLrV</recordid><startdate>20230828</startdate><enddate>20230828</enddate><creator>Salcedo, Andrea C</creator><creator>Yun, Jane</creator><creator>Carter, Cody</creator><creator>Hart, Elaine</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230828</creationdate><title>Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding</title><author>Salcedo, Andrea C ; Yun, Jane ; Carter, Cody ; Hart, Elaine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6b8f0787953fcd431372aa74e5ea2cab5c490fe768b7c9a5b07fb85af057c2ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Atherosclerosis</topic><topic>Carbohydrates</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases</topic><topic>Care and treatment</topic><topic>Cytokines</topic><topic>Diet, Carbohydrate-Restricted</topic><topic>Disease prevention</topic><topic>Endometrium</topic><topic>Epidermal growth factor</topic><topic>Female</topic><topic>Fibroids</topic><topic>Health aspects</topic><topic>Health care policy</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Hypertension</topic><topic>Hysterectomy</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Leiomyoma</topic><topic>Medical care, Cost of</topic><topic>Menstruation</topic><topic>Metabolism</topic><topic>Obesity</topic><topic>Opinion</topic><topic>Ovaries</topic><topic>Polycystic ovary syndrome</topic><topic>Polyps</topic><topic>Prevention</topic><topic>Risk factors</topic><topic>Smooth muscle</topic><topic>Tumor necrosis factor-TNF</topic><topic>Uterine bleeding</topic><topic>Uterine Hemorrhage</topic><topic>Vascular endothelial growth factor</topic><topic>Weight control</topic><topic>Women</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salcedo, Andrea C</creatorcontrib><creatorcontrib>Yun, Jane</creatorcontrib><creatorcontrib>Carter, Cody</creatorcontrib><creatorcontrib>Hart, Elaine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salcedo, Andrea C</au><au>Yun, Jane</au><au>Carter, Cody</au><au>Hart, Elaine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2023-08-28</date><risdate>2023</risdate><volume>15</volume><issue>17</issue><spage>3760</spage><pages>3760-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Therapeutic carbohydrate restriction diets have been becoming increasingly popular over the years, resulting in dramatic weight loss and an improvement in metabolic disorders. Obesity, insulin resistance, and diabetes are the risk factors for many gynecologic morbidities such as uterine leiomyoma, endometrial polyps, and polycystic ovarian syndrome. There is evidence suggesting that the pathogenesis of cardiovascular disease is similar to that seen in many causes of abnormal uterine bleeding. We aim to explain how cardiovascular disease risk factor reduction with the use of therapeutic carbohydrate restriction may prevent and potentially treat these gynecologic disorders.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37686792</pmid><doi>10.3390/nu15173760</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2072-6643 |
| ispartof | Nutrients, 2023-08, Vol.15 (17), p.3760 |
| issn | 2072-6643 2072-6643 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10490487 |
| source | Electronic Journals Library; Open Access: PubMed Central; MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; PubMed Central Open Access |
| subjects | Atherosclerosis Carbohydrates Cardiovascular disease Cardiovascular Diseases Care and treatment Cytokines Diet, Carbohydrate-Restricted Disease prevention Endometrium Epidermal growth factor Female Fibroids Health aspects Health care policy Humans Hyperplasia Hypertension Hysterectomy Inflammation Insulin resistance Leiomyoma Medical care, Cost of Menstruation Metabolism Obesity Opinion Ovaries Polycystic ovary syndrome Polyps Prevention Risk factors Smooth muscle Tumor necrosis factor-TNF Uterine bleeding Uterine Hemorrhage Vascular endothelial growth factor Weight control Women Womens health |
| title | Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T10%3A01%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Carbohydrate%20Restriction%20as%20a%20Metabolic%20Modality%20for%20the%20Prevention%20and%20Treatment%20of%20Abnormal%20Uterine%20Bleeding&rft.jtitle=Nutrients&rft.au=Salcedo,%20Andrea%20C&rft.date=2023-08-28&rft.volume=15&rft.issue=17&rft.spage=3760&rft.pages=3760-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu15173760&rft_dat=%3Cgale_pubme%3EA764267947%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2862708503&rft_id=info:pmid/37686792&rft_galeid=A764267947&rfr_iscdi=true |